Finaosta invests in Bio4Dreams

8 January 2026
  • Corporate
  • /

    Finaosta enters the share capital of Bio4Dreams and, together with a Memorandum of Understanding, launches new strategic and operational activities in the Aosta Valley.

    On October 24, 2025, Finaosta subscribed to a €1 million capital increase in Bio4Dreams.

    The transaction represents a strategic step toward the creation of the VITTe Project (Valle d’Aosta for Innovation and Technology Transfer), the new regional hub for innovation and technology transfer.

    Finaosta investe in Bio4Dreams / Pietro Conti, Mattia Michele Sisto, Herbert Tovagliari, Elisabetta Borello, Luigi Bertschy, Renzo Testolin, Laura Ferro, Marco Linty
    Standing from left: Pietro Conti, CEO & Co-Founder of Bio4Dreams; Mattia Michele Sisto, Director General of Finaosta; Herbert Tovagliari, Director of Equity Investments at Finaosta; Elisabetta Borello, Co-Founder and VP Strategy & External Relations at Bio4Dreams.
    Seated from left: Luigi Bertschy, Vice President of the Autonomous Region of Aosta Valley and Regional Councillor for Economic Development, Education and Employment, Transport and Sustainable Mobility; Renzo Testolin, President of the Autonomous Region of Aosta Valley; Laura Ferro, President of Bio4Dreams; Marco Linty, President of Finaosta.

    Finaosta and Bio4Dreams: a long-term vision to create new value in the Aosta Valley

    Finaosta S.p.A. is the regional financial institution wholly owned by the Autonomous Region of Aosta Valley.

    Bio4Dreams views the region as a particularly favorable context for new developments in the Life Sciences: a clearly defined and compact territory, ideal for implementing highly innovative healthcare models and solutions with measurable outcomes and continuous monitoring.

    The local ecosystem stands out for the presence of centers of excellence such as CMP3VdA (Center for Personalized, Preventive and Predictive Medicine in the Aosta Valley), established within the 5000genomi@VdA research project. The center is the result of a consortium led by the Italian Institute of Technology (IIT) and involves the University of the Aosta Valley, the AOU Città della Salute e della Scienza of Turin, the Fondazione Clément Fillietroz-ONLUS – Astronomical Observatory of the Aosta Valley, and Engineering D.HUB.

    Within this innovation-oriented framework, the VITTe Project is positioned as a strategic initiative aimed at launching actions and policies to support the creation and consolidation of new value across the regional territory.

    The collaboration between Finaosta and Bio4Dreams has developed over time through concrete initiatives. Since 2022, Bio4Dreams has been active in the Aosta Valley, supporting entrepreneurial valorization in the healthcare sector, mapping the local ecosystem, and facilitating the participation of startups and network companies in funded initiatives, including the SaluteDerm and COBALT projects under the R&S Health Aggregations Call. These experiences have helped build a structured dialogue with local institutions, research centers, and businesses.

    The investment and the Memorandum of Understanding

    Following Finaosta’s €999,978 investment in the share capital of Bio4Dreams, the VITTe Project will be launched in accordance with the Memorandum of Understanding. At the same time, the new Bio4Dreams office in Aosta will become operational, tasked with coordinating local activities, promoting joint initiatives with regional stakeholders, and connecting the Aosta Valley to major national and international ecosystems.

    The Memorandum of Understanding focuses on three strategic pillars aligned with the region’s strengths:

    • Innovation for citizens’ health, with applications in telemedicine, personalized medicine, and data-driven healthcare;
    • Wellness and nutraceuticals, ranging from personalized nutrition to the valorization of natural active ingredients;
    • Agrifood, bioenergy, and green tech, including Agriculture 4.0 initiatives, circular economy models, and resource optimization.

    Key activities include pilot projects and field tests, Proof of Concept programs, and the valorization of local initiatives through public–private partnerships.

    Expected results over a five-year horizon include the creation of new startups in the region, the generation of skilled employment, capital raising through equity and public funding instruments, and steady growth in the production value of supported companies.

    Through this transaction, Finaosta and Bio4Dreams strengthen a shared path aimed at positioning the Aosta Valley as a center of excellence for Life Sciences innovation. As part of the agreement, Finaosta also acquires the right to appoint one member to the Board of Directors and one member to the Investment Committee of Bio4Dreams, ensuring both strategic and technical oversight of the investment.

    “The Aosta Valley represents an extraordinary ‘pilot ground’ for applying highly innovative methodologies, solutions, and processes capable of delivering tangible improvements to the healthcare system and generating positive impacts on both citizens’ quality of life and the regional economy. Bio4Dreams approaches this new and challenging scenario with awareness and enthusiasm, alongside institutions that have strongly believed in the potential to create new enterprises and value in the region.”

    Elisabetta Borello, Co-Founder, VP Strategy & External Relations of Bio4Dreams 

    Finaosta’s entry into the share capital of Bio4Dreams represents a strategic investment for the Aosta Valley. Our goal is to strengthen the regional innovation ecosystem by supporting the creation of new enterprises and the growth of skills in the Life Sciences sector. This transaction confirms Finaosta’s role as a driver of development and a partner for the most dynamic and innovative organizations.”

    Marco Linty, President of Finaosta

    Finaosta invests in Bio4Dreams

    8 January 2026
  • Corporate
  • /

    Finaosta enters the share capital of Bio4Dreams and, together with a Memorandum of Understanding, launches new strategic and operational activities in the Aosta Valley.

    On October 24, 2025, Finaosta subscribed to a €1 million capital increase in Bio4Dreams.

    The transaction represents a strategic step toward the creation of the VITTe Project (Valle d’Aosta for Innovation and Technology Transfer), the new regional hub for innovation and technology transfer.

    Finaosta investe in Bio4Dreams / Pietro Conti, Mattia Michele Sisto, Herbert Tovagliari, Elisabetta Borello, Luigi Bertschy, Renzo Testolin, Laura Ferro, Marco Linty
    Standing from left: Pietro Conti, CEO & Co-Founder of Bio4Dreams; Mattia Michele Sisto, Director General of Finaosta; Herbert Tovagliari, Director of Equity Investments at Finaosta; Elisabetta Borello, Co-Founder and VP Strategy & External Relations at Bio4Dreams.
    Seated from left: Luigi Bertschy, Vice President of the Autonomous Region of Aosta Valley and Regional Councillor for Economic Development, Education and Employment, Transport and Sustainable Mobility; Renzo Testolin, President of the Autonomous Region of Aosta Valley; Laura Ferro, President of Bio4Dreams; Marco Linty, President of Finaosta.

    Finaosta and Bio4Dreams: a long-term vision to create new value in the Aosta Valley

    Finaosta S.p.A. is the regional financial institution wholly owned by the Autonomous Region of Aosta Valley.

    Bio4Dreams views the region as a particularly favorable context for new developments in the Life Sciences: a clearly defined and compact territory, ideal for implementing highly innovative healthcare models and solutions with measurable outcomes and continuous monitoring.

    The local ecosystem stands out for the presence of centers of excellence such as CMP3VdA (Center for Personalized, Preventive and Predictive Medicine in the Aosta Valley), established within the 5000genomi@VdA research project. The center is the result of a consortium led by the Italian Institute of Technology (IIT) and involves the University of the Aosta Valley, the AOU Città della Salute e della Scienza of Turin, the Fondazione Clément Fillietroz-ONLUS – Astronomical Observatory of the Aosta Valley, and Engineering D.HUB.

    Within this innovation-oriented framework, the VITTe Project is positioned as a strategic initiative aimed at launching actions and policies to support the creation and consolidation of new value across the regional territory.

    The collaboration between Finaosta and Bio4Dreams has developed over time through concrete initiatives. Since 2022, Bio4Dreams has been active in the Aosta Valley, supporting entrepreneurial valorization in the healthcare sector, mapping the local ecosystem, and facilitating the participation of startups and network companies in funded initiatives, including the SaluteDerm and COBALT projects under the R&S Health Aggregations Call. These experiences have helped build a structured dialogue with local institutions, research centers, and businesses.

    The investment and the Memorandum of Understanding

    Following Finaosta’s €999,978 investment in the share capital of Bio4Dreams, the VITTe Project will be launched in accordance with the Memorandum of Understanding. At the same time, the new Bio4Dreams office in Aosta will become operational, tasked with coordinating local activities, promoting joint initiatives with regional stakeholders, and connecting the Aosta Valley to major national and international ecosystems.

    The Memorandum of Understanding focuses on three strategic pillars aligned with the region’s strengths:

    • Innovation for citizens’ health, with applications in telemedicine, personalized medicine, and data-driven healthcare;
    • Wellness and nutraceuticals, ranging from personalized nutrition to the valorization of natural active ingredients;
    • Agrifood, bioenergy, and green tech, including Agriculture 4.0 initiatives, circular economy models, and resource optimization.

    Key activities include pilot projects and field tests, Proof of Concept programs, and the valorization of local initiatives through public–private partnerships.

    Expected results over a five-year horizon include the creation of new startups in the region, the generation of skilled employment, capital raising through equity and public funding instruments, and steady growth in the production value of supported companies.

    Through this transaction, Finaosta and Bio4Dreams strengthen a shared path aimed at positioning the Aosta Valley as a center of excellence for Life Sciences innovation. As part of the agreement, Finaosta also acquires the right to appoint one member to the Board of Directors and one member to the Investment Committee of Bio4Dreams, ensuring both strategic and technical oversight of the investment.

    “The Aosta Valley represents an extraordinary ‘pilot ground’ for applying highly innovative methodologies, solutions, and processes capable of delivering tangible improvements to the healthcare system and generating positive impacts on both citizens’ quality of life and the regional economy. Bio4Dreams approaches this new and challenging scenario with awareness and enthusiasm, alongside institutions that have strongly believed in the potential to create new enterprises and value in the region.”

    Elisabetta Borello, Co-Founder, VP Strategy & External Relations of Bio4Dreams 

    Finaosta’s entry into the share capital of Bio4Dreams represents a strategic investment for the Aosta Valley. Our goal is to strengthen the regional innovation ecosystem by supporting the creation of new enterprises and the growth of skills in the Life Sciences sector. This transaction confirms Finaosta’s role as a driver of development and a partner for the most dynamic and innovative organizations.”

    Marco Linty, President of Finaosta

    Finaosta invests in Bio4Dreams

    8 January 2026
  • Corporate
  • /

    Finaosta enters the share capital of Bio4Dreams and, together with a Memorandum of Understanding, launches new strategic and operational activities in the Aosta Valley.

    On October 24, 2025, Finaosta subscribed to a €1 million capital increase in Bio4Dreams.

    The transaction represents a strategic step toward the creation of the VITTe Project (Valle d’Aosta for Innovation and Technology Transfer), the new regional hub for innovation and technology transfer.

    Finaosta investe in Bio4Dreams / Pietro Conti, Mattia Michele Sisto, Herbert Tovagliari, Elisabetta Borello, Luigi Bertschy, Renzo Testolin, Laura Ferro, Marco Linty
    Standing from left: Pietro Conti, CEO & Co-Founder of Bio4Dreams; Mattia Michele Sisto, Director General of Finaosta; Herbert Tovagliari, Director of Equity Investments at Finaosta; Elisabetta Borello, Co-Founder and VP Strategy & External Relations at Bio4Dreams.
    Seated from left: Luigi Bertschy, Vice President of the Autonomous Region of Aosta Valley and Regional Councillor for Economic Development, Education and Employment, Transport and Sustainable Mobility; Renzo Testolin, President of the Autonomous Region of Aosta Valley; Laura Ferro, President of Bio4Dreams; Marco Linty, President of Finaosta.

    Finaosta and Bio4Dreams: a long-term vision to create new value in the Aosta Valley

    Finaosta S.p.A. is the regional financial institution wholly owned by the Autonomous Region of Aosta Valley.

    Bio4Dreams views the region as a particularly favorable context for new developments in the Life Sciences: a clearly defined and compact territory, ideal for implementing highly innovative healthcare models and solutions with measurable outcomes and continuous monitoring.

    The local ecosystem stands out for the presence of centers of excellence such as CMP3VdA (Center for Personalized, Preventive and Predictive Medicine in the Aosta Valley), established within the 5000genomi@VdA research project. The center is the result of a consortium led by the Italian Institute of Technology (IIT) and involves the University of the Aosta Valley, the AOU Città della Salute e della Scienza of Turin, the Fondazione Clément Fillietroz-ONLUS – Astronomical Observatory of the Aosta Valley, and Engineering D.HUB.

    Within this innovation-oriented framework, the VITTe Project is positioned as a strategic initiative aimed at launching actions and policies to support the creation and consolidation of new value across the regional territory.

    The collaboration between Finaosta and Bio4Dreams has developed over time through concrete initiatives. Since 2022, Bio4Dreams has been active in the Aosta Valley, supporting entrepreneurial valorization in the healthcare sector, mapping the local ecosystem, and facilitating the participation of startups and network companies in funded initiatives, including the SaluteDerm and COBALT projects under the R&S Health Aggregations Call. These experiences have helped build a structured dialogue with local institutions, research centers, and businesses.

    The investment and the Memorandum of Understanding

    Following Finaosta’s €999,978 investment in the share capital of Bio4Dreams, the VITTe Project will be launched in accordance with the Memorandum of Understanding. At the same time, the new Bio4Dreams office in Aosta will become operational, tasked with coordinating local activities, promoting joint initiatives with regional stakeholders, and connecting the Aosta Valley to major national and international ecosystems.

    The Memorandum of Understanding focuses on three strategic pillars aligned with the region’s strengths:

    • Innovation for citizens’ health, with applications in telemedicine, personalized medicine, and data-driven healthcare;
    • Wellness and nutraceuticals, ranging from personalized nutrition to the valorization of natural active ingredients;
    • Agrifood, bioenergy, and green tech, including Agriculture 4.0 initiatives, circular economy models, and resource optimization.

    Key activities include pilot projects and field tests, Proof of Concept programs, and the valorization of local initiatives through public–private partnerships.

    Expected results over a five-year horizon include the creation of new startups in the region, the generation of skilled employment, capital raising through equity and public funding instruments, and steady growth in the production value of supported companies.

    Through this transaction, Finaosta and Bio4Dreams strengthen a shared path aimed at positioning the Aosta Valley as a center of excellence for Life Sciences innovation. As part of the agreement, Finaosta also acquires the right to appoint one member to the Board of Directors and one member to the Investment Committee of Bio4Dreams, ensuring both strategic and technical oversight of the investment.

    “The Aosta Valley represents an extraordinary ‘pilot ground’ for applying highly innovative methodologies, solutions, and processes capable of delivering tangible improvements to the healthcare system and generating positive impacts on both citizens’ quality of life and the regional economy. Bio4Dreams approaches this new and challenging scenario with awareness and enthusiasm, alongside institutions that have strongly believed in the potential to create new enterprises and value in the region.”

    Elisabetta Borello, Co-Founder, VP Strategy & External Relations of Bio4Dreams 

    Finaosta’s entry into the share capital of Bio4Dreams represents a strategic investment for the Aosta Valley. Our goal is to strengthen the regional innovation ecosystem by supporting the creation of new enterprises and the growth of skills in the Life Sciences sector. This transaction confirms Finaosta’s role as a driver of development and a partner for the most dynamic and innovative organizations.”

    Marco Linty, President of Finaosta

    Finaosta invests in Bio4Dreams

    8 January 2026
  • Corporate
  • /

    Finaosta enters the share capital of Bio4Dreams and, together with a Memorandum of Understanding, launches new strategic and operational activities in the Aosta Valley.

    On October 24, 2025, Finaosta subscribed to a €1 million capital increase in Bio4Dreams.

    The transaction represents a strategic step toward the creation of the VITTe Project (Valle d’Aosta for Innovation and Technology Transfer), the new regional hub for innovation and technology transfer.

    Finaosta investe in Bio4Dreams / Pietro Conti, Mattia Michele Sisto, Herbert Tovagliari, Elisabetta Borello, Luigi Bertschy, Renzo Testolin, Laura Ferro, Marco Linty
    Standing from left: Pietro Conti, CEO & Co-Founder of Bio4Dreams; Mattia Michele Sisto, Director General of Finaosta; Herbert Tovagliari, Director of Equity Investments at Finaosta; Elisabetta Borello, Co-Founder and VP Strategy & External Relations at Bio4Dreams.
    Seated from left: Luigi Bertschy, Vice President of the Autonomous Region of Aosta Valley and Regional Councillor for Economic Development, Education and Employment, Transport and Sustainable Mobility; Renzo Testolin, President of the Autonomous Region of Aosta Valley; Laura Ferro, President of Bio4Dreams; Marco Linty, President of Finaosta.

    Finaosta and Bio4Dreams: a long-term vision to create new value in the Aosta Valley

    Finaosta S.p.A. is the regional financial institution wholly owned by the Autonomous Region of Aosta Valley.

    Bio4Dreams views the region as a particularly favorable context for new developments in the Life Sciences: a clearly defined and compact territory, ideal for implementing highly innovative healthcare models and solutions with measurable outcomes and continuous monitoring.

    The local ecosystem stands out for the presence of centers of excellence such as CMP3VdA (Center for Personalized, Preventive and Predictive Medicine in the Aosta Valley), established within the 5000genomi@VdA research project. The center is the result of a consortium led by the Italian Institute of Technology (IIT) and involves the University of the Aosta Valley, the AOU Città della Salute e della Scienza of Turin, the Fondazione Clément Fillietroz-ONLUS – Astronomical Observatory of the Aosta Valley, and Engineering D.HUB.

    Within this innovation-oriented framework, the VITTe Project is positioned as a strategic initiative aimed at launching actions and policies to support the creation and consolidation of new value across the regional territory.

    The collaboration between Finaosta and Bio4Dreams has developed over time through concrete initiatives. Since 2022, Bio4Dreams has been active in the Aosta Valley, supporting entrepreneurial valorization in the healthcare sector, mapping the local ecosystem, and facilitating the participation of startups and network companies in funded initiatives, including the SaluteDerm and COBALT projects under the R&S Health Aggregations Call. These experiences have helped build a structured dialogue with local institutions, research centers, and businesses.

    The investment and the Memorandum of Understanding

    Following Finaosta’s €999,978 investment in the share capital of Bio4Dreams, the VITTe Project will be launched in accordance with the Memorandum of Understanding. At the same time, the new Bio4Dreams office in Aosta will become operational, tasked with coordinating local activities, promoting joint initiatives with regional stakeholders, and connecting the Aosta Valley to major national and international ecosystems.

    The Memorandum of Understanding focuses on three strategic pillars aligned with the region’s strengths:

    • Innovation for citizens’ health, with applications in telemedicine, personalized medicine, and data-driven healthcare;
    • Wellness and nutraceuticals, ranging from personalized nutrition to the valorization of natural active ingredients;
    • Agrifood, bioenergy, and green tech, including Agriculture 4.0 initiatives, circular economy models, and resource optimization.

    Key activities include pilot projects and field tests, Proof of Concept programs, and the valorization of local initiatives through public–private partnerships.

    Expected results over a five-year horizon include the creation of new startups in the region, the generation of skilled employment, capital raising through equity and public funding instruments, and steady growth in the production value of supported companies.

    Through this transaction, Finaosta and Bio4Dreams strengthen a shared path aimed at positioning the Aosta Valley as a center of excellence for Life Sciences innovation. As part of the agreement, Finaosta also acquires the right to appoint one member to the Board of Directors and one member to the Investment Committee of Bio4Dreams, ensuring both strategic and technical oversight of the investment.

    “The Aosta Valley represents an extraordinary ‘pilot ground’ for applying highly innovative methodologies, solutions, and processes capable of delivering tangible improvements to the healthcare system and generating positive impacts on both citizens’ quality of life and the regional economy. Bio4Dreams approaches this new and challenging scenario with awareness and enthusiasm, alongside institutions that have strongly believed in the potential to create new enterprises and value in the region.”

    Elisabetta Borello, Co-Founder, VP Strategy & External Relations of Bio4Dreams 

    Finaosta’s entry into the share capital of Bio4Dreams represents a strategic investment for the Aosta Valley. Our goal is to strengthen the regional innovation ecosystem by supporting the creation of new enterprises and the growth of skills in the Life Sciences sector. This transaction confirms Finaosta’s role as a driver of development and a partner for the most dynamic and innovative organizations.”

    Marco Linty, President of Finaosta